Report period | 2018 | 2019 | 2020 | Q3 21 |
---|---|---|---|---|
End date of the reporting period | ||||
Capitalization, € | ||||
Capitalization, $ | ||||
Enterprise Value | ||||
Book Value | ||||
Shareholders Book Value | ||||
Current liabilities | ||||
Noncurrent liabilities | ||||
Total liabilities | ||||
Debt | ||||
Cash and cash equivalents | ||||
Net debt | ||||
Assets | ||||
Total ordinary shares | ||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
CVAC:US | CureVac BV | Common share | - | NL0015436031 | $3.05 |
Company name | CureVac BV |
---|---|
Business address | PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0 |
Mailing address | PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 |
Website | www.curevac.com |
Information disclosure | www.sec.gov |